Phase 1-2 Study of ADXS11-001 or MEDI4736 Alone or Combo In Cervical or HPV+ Head & Neck Cancer
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02291055 |
|
Recruitment Status : Unknown
Verified February 2020 by Advaxis, Inc..
Recruitment status was: Active, not recruiting
First Posted : November 14, 2014
Last Update Posted : February 19, 2020
|
Sponsor:
Advaxis, Inc.
Collaborator:
MedImmune LLC
Information provided by (Responsible Party):
Advaxis, Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Unknown |
|---|---|
| Actual Primary Completion Date : | August 2019 |
| Estimated Study Completion Date : | May 31, 2021 |